Genome-wide significant locus for Research Diagnostic Criteria Schizoaffective Disorder Bipolar type

Am J Med Genet B Neuropsychiatr Genet. 2017 Dec;174(8):767-771. doi: 10.1002/ajmg.b.32572. Epub 2017 Aug 29.

Abstract

Studies have suggested that Research Diagnostic Criteria for Schizoaffective Disorder Bipolar type (RDC-SABP) might identify a more genetically homogenous subgroup of bipolar disorder. Aiming to identify loci associated with RDC-SABP, we have performed a replication study using independent RDC-SABP cases (n = 144) and controls (n = 6,559), focusing on the 10 loci that reached a p-value <10-5 for RDC-SABP in the Wellcome Trust Case Control Consortium (WTCCC) bipolar disorder sample. Combining the WTCCC and replication datasets by meta-analysis (combined RDC-SABP, n = 423, controls, n = 9,494), we observed genome-wide significant association at one SNP, rs2352974, located within the intron of the gene TRAIP on chromosome 3p21.31 (p-value, 4.37 × 10-8 ). This locus did not reach genome-wide significance in bipolar disorder or schizophrenia large Psychiatric Genomic Consortium datasets, suggesting that it may represent a relatively specific genetic risk for the bipolar subtype of schizoaffective disorder.

Keywords: Research Diagnostic Criteria; SABP; TRAIP; schizoaffective disorder bipolar type.

MeSH terms

  • Bipolar Disorder / diagnosis*
  • Bipolar Disorder / genetics
  • Case-Control Studies
  • Genetic Markers*
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study*
  • Humans
  • Meta-Analysis as Topic
  • Polymorphism, Single Nucleotide*
  • Schizophrenia / diagnosis*
  • Schizophrenia / genetics

Substances

  • Genetic Markers